AzTrials
AzTrials

Kidney CalculiNCT07780409

Flexible Ureteroscopy for Large Renal Stones in Children

A study testing Flexible Ureteroscopic Stone Disintegration in people with Kidney Calculi, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This prospective single-arm interventional study evaluated the efficacy and safety of flexible ureteroscopy for the treatment of large renal stones measuring 2 cm or more in pediatric patients. Read more about this study

Who is it for?
Ages 0 to 13 years
Conditions the study is for
Kidney Calculi
What is being tested?
Flexible Ureteroscopic Stone Disintegration
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteEgypt
Study dates
1 Aug 2025to 1 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Pediatric patients diagnosed with renal stones.
  • Renal stone size ≥2 cm.
  • Age younger than 14 years.

Who cannot join

  • Uncontrolled urinary tract infection.
  • Impaired renal function.
  • Abnormal anatomical location of the kidney.
  • Congenital renal or ureteric anomalies.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ain Shams University Hospitals

    Cairo, 11511

Other trials in Egypt

About this study

Official title: Flexible Ureteroscopic Stone Disintegration in Pediatric Age Group for Large Renal Stones (≥2 cm)

This prospective single-arm interventional study evaluated the efficacy and safety of flexible ureteroscopy for the treatment of large renal stones measuring 2 cm or more in pediatric patients. All enrolled participants underwent flexible ureteroscopic stone disintegration using a single-use flexible ureteroscope and Holmium laser lithotripsy. The study was designed to assess whether this minimally invasive approach could provide effective stone clearance with acceptable perioperative safety in children with large renal stones.

Conditions
Kidney Calculi
Being tested
Flexible Ureteroscopic Stone Disintegration
Keywords
Pediatric Urolithiasis, Renal Stones, Large Renal Stones, Flexible Ureteroscopy, Flexible Ureterorenoscopy, Single-Use Flexible Ureteroscope, Laser Lithotripsy, Holmium:YAG Laser
Medical subject headings
Kidney Calculi, Nephrolithiasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Flexible Ureteroscopic Stone DisintegrationProcedure or surgery

    Flexible ureteroscopy was performed using a 7.5-Fr single-use flexible ureteroscope. Renal stones were fragmented with a Holmium:YAG laser. A ureteral access sheath was used when feasible, and a double-J ureteral stent was placed at the end of the procedure.

Study groups in NCT07780409
Study groupRoleWhat they receive
Flexible Ureteroscopic Stone DisintegrationExperimentalPediatric patients with large renal stones (≥2 cm) underwent flexible ureteroscopic stone disintegration using a 7.5-Fr single-use flexible ureteroscope and Holmium:YAG laser lithotripsy. A ureteral access sheath was used when feasible, and a double-J ureteral stent was inserted at the end of the procedure.
Receives: Procedure: Flexible Ureteroscopic Stone Disintegration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stone-Free Rate After Flexible Ureteroscopic Stone Disintegration

    Stone-free status was assessed by computed tomography of the urinary tract (CTUT) after flexible ureteroscopic stone disintegration. The proportion of participants meeting the study-defined criteria for stone-free status was recorded.

    Measured: 1 month after the procedure

Secondary outcomes (1)
  1. Operative Time

    Duration of the flexible ureteroscopic procedure was recorded for each participant.

    Measured: Intraoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2026
  2. Study start1 Aug 2025
  3. Primary completion1 Feb 2026
  4. Study completion1 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
All enrolled pediatric patients with large renal stones underwent flexible ureteroscopic stone disintegration using a single-use flexible ureteroscope and Holmium:YAG laser.
Masking
None (open label)
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07780409
Sponsor's protocol ID
FMASU MS 391/2025
Status last verified
Aug 2026
First submitted
19 Aug 2026
Last updated
21 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Flexible Ureteroscopic Stone Disintegration in people with Kidney Calculi, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stone-Free Rate After Flexible Ureteroscopic Stone Disintegration (time frame: 1 month after the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in